We sought to identify predictors of diabetes diagnosed before hemochromatosis.
Hemochromatosis due to homozygosity for the C282Y mutation of the HFE gene on chromosome 6p21.3 occurs in 0.3-0.6% of people of Northwestern European descent (1) (2) (3) . Iron overload, especially if severe, may cause cirrhosis, primary liver cancer, diabetes, other endocrinopathy, and cardiomyopathy (3, 4) . A diagnostic triad for hemochromatosis of hyperpigmentation, diabetes, and cirrhosis was proposed in the 19th century (5) . Reports from the late 19th century to the mid-20th century demonstrated that ;80% of patients with hemochromatosis had diabetes, typically associated with cirrhosis and severe hemosiderin deposition and associated morphologic abnormalities in the pancreatic acini and islets of Langerhans (6, 7) . Relative specificity of iron deposition for the b-cells of the pancreatic islets in hemochromatosis was described in 1956 (8) .
In 1968, Balcerzak et al. (9) reported that the prevalence of diabetes was high (47%) in people with normal iron stores in five hemochromatosis kinships. In 1972, Dymock et al. (10) reported that 25% of 68 hemochromatosis patients with diabetes had first-degree relatives who also had diabetes, whereas only 4% of 42 hemochromatosis patients without diabetes had a first-degree relative with diabetes. These observations, analyzed with univariable techniques, suggested that a heritable factor(s) increases the risk of diabetes in people with hemochromatosis.
The diagnosis of hemochromatosis changed in 1996 with the discovery of the HFE gene and the C282Y polymorphism (1) . Thereafter, more people with abnormal iron phenotypes were confirmed to have hemochromatosis using a genetic criterion (C282Y homozygosity) than with the traditional diagnostic triad, although ;10% of Western European whites with hemochromatosis phenotypes do not have C282Y homozygosity (1) . In two hemochromatosis case series from the 21st century (11, 12) , the prevalence of diabetes in people with hemochromatosis phenotypes was much lower, i.e., 23 and 22%, respectively, than typically reported in the 20th century.
In one study, all subjects were referred from a hemochromatosis clinic (11) . In the other study, subjects were ascertained due to clinical suspicion, family screening, or detection of hyperferritinemia on routine health checks (12) . The proportions of hemochromatosis subjects with HFE C282Y homozygosity in the two reports were 87% (26 of 30) and 78% (185 of 237), respectively (11, 12) . In the second report, neither serum ferritin (SF) level at diagnosis nor cirrhosis nor HFE genotype was significantly associated with the occurrence of diabetes in people with hemochromatosis phenotypes by univariable analyses (12) . Family history of diabetes was not evaluated in either of these reports (11, 12) .
Thus, a critical multivariable assessment of the relationships of the type(s) of diabetes, severity of iron overload, occurrence of liver disease, family history of diabetes, and other variables in people with hemochromatosis and HFE C282Y homozygosity has not been reported (4) . We sought to identify factors associated with increased risk of diabetes at diagnosis in 159 nonscreening hemochromatosis probands, each of whom also had HFE C282Y homozygosity. The basis of hemochromatosis diagnosis in each proband was an abnormal iron phenotype discovered in a medical care setting, not in population or clinic screening or in a family study. Available independent variables were age, sex, BMI, proband reports of diabetes in first-degree family members, heavy ethanol consumption, cigarette smoking, concomitant liver disorders, hand arthropathy, quantities of iron removed by phlebotomy (QFe), and common HLA-A and -B haplotypes. Our results are discussed in the context of previous descriptions of the relationships of iron overload, comorbid conditions, and family history in the occurrence of diabetes in HFE hemochromatosis.
RESEARCH DESIGN AND METHODS

Selection of Hemochromatosis Probands
The performance of this work was approved by the institutional review board of Brookwood Medical Center. We conducted computerized and manual searches of medical records to identify patients who were evaluated for hemochromatosis because they had elevated values of transferrin saturation (TS) or SF. Each person selected for this study was a white adult (.18 years of age) and the first in his/her respective family to be diagnosed to have hemochromatosis (proband). We included probands who a) were diagnosed to have hemochromatosis during routine medical care, not as a consequence of screening; b) had elevated SF levels at diagnosis (men .300 mg/L; women .200 mg/L) (2,3); c) had genotype HFE C282Y/C282Y; d) had undergone HLA-A and -B haplotyping; e) completed iron depletion therapy by phlebotomy; and f) resided in central Alabama. Each proband was diagnosed to have hemochromatosis in the interval 1976-2010. Each proband was evaluated for iron overload and associated complications, as appropriate (3) . BMI was computed as described previously (13 
Diabetes in Hemochromatosis Probands
Probands with diabetes were identified and characterized by referring physicians, our queries regarding diabetes, and medication reviews. Probands were diagnosed to have diabetes before hemochromatosis was diagnosed. Diabetes was defined and subclassified according to the criteria of the American Diabetes Association (22) . We excluded one proband with diabetes, a woman who had undergone pancreatectomy for management of adenocarcinoma of the pancreas.
Family History of Diabetes
Reports of first-degree relatives (parents, full siblings, and children) with diabetes were elicited from each proband and documented in his/her medical record at the time of initial evaluation.
Definitions of Smoking and Heavy Ethanol Consumption
Smoking was defined as the self-report of daily cigarette smoking for $5 years. Heavy ethanol consumption was defined as the self-reported consumption of $60 g ethanol per day for $5 years.
Definitions of Liver Conditions
Probands were classified as having elevated serum ALT or AST if either of their levels were higher than the respective upper reference limits (.2 SD above mean; .40 IU/L). Nonalcoholic fatty liver disease (NAFLD) was defined as steatosis or steatohepatitis detected on liver biopsy specimens or by typical increase of hepatic echogenicity detected by ultrasonography, in the absence of selfreports of heavy ethanol consumption. Chronic hepatitis B or C was defined as positivity for HB s Ag or hepatitis C antibody, respectively, in association with other clinical or liver biopsy abnormalities consistent with chronic viral hepatitis. Liver biopsy was performed in all probands with SF .1,000 mg/L and in other probands whose evaluations suggested that they had an undiagnosed liver disorder other than that attributable to iron overload. Cirrhosis was defined by pathologist interpretations of liver biopsy specimens.
Definition of Hemochromatosis Hand Arthropathy
We evaluated this manifestation because it is typically associated with severe iron overload (4). Probands who had symptoms or physical examination findings in hand joints suggestive or typical of hemochromatosis arthropathy at diagnosis were evaluated with hand radiographs and other studies, as appropriate. The objective criteria we used to classify probands as having hemochromatosis hand arthropathy included 1) symmetrical polyarthropathy, typically with hypertrophy and related abnormalities of metacarpophalangeal and proximal interphalangeal joints; 2) subchondral cysts with sclerotic margins at the metacarpal heads, especially of the second and third metacarpophalangeal joints; and 3) joint space narrowing, usually with asymmetric cartilage loss (4, 23) . Other abnormalities were detected in some probands, especially those with severe arthropathy (4, 23) .
Iron Removed by Phlebotomy
Iron depletion therapy, defined as the periodic removal of blood to eliminate storage iron, was complete when SF was #20 mg/L (3). QFe was estimated as 200 mg Fe per unit of blood (450-500 mL) 
RESULTS
General Characteristics of 159 Hemochromatosis Probands
There were 102 men (64.2%) ( Table 1 ). The proportion of men, mean BMI, and prevalence of diabetes reports in firstdegree family members were higher in probands with diabetes than in probands without diabetes. We observed no other significant differences between probands with and without diabetes ( Table 2 ).
Logistic Regression on Diabetes at Diagnosis
We performed a multiple logistic regression on diabetes at diagnosis of hemochromatosis using 16 independent variables. The only variable significantly associated with diabetes in probands was reports of diabetes in first-degree family members (OR 10.9 [95% CI 3.4-35.2]; P , 0.0001). This 16-factor model explained 30.7% of total deviance contributing to diabetes at diagnosis of hemochromatosis (x 2 = 41.39; P = 0.0005).
To obtain the best fitting model while minimizing the number of independent variables, we performed likelihood ratio tests and determined that only age, male sex, BMI, family history of diabetes, and heavy ethanol consumption would be possible significant contributors to a reduced model. Using these five observations as independent variables, a reduced logistic regression model demonstrated that only family history of diabetes and BMI were significant predictors of diabetes (P , 0.0001 and P = 0.049, respectively). The corresponding ORs and 95% CIs for these independent variables were 8.5 (2.9-24.8) and 1.1 (1.0-1.2). This five-factor model explained 26.0% of total deviance contributing to diabetes at diagnosis of hemochromatosis (x 2 = 34.90; P , 0.0001).
In another analysis, we combined heavy ethanol consumption, elevated serum ALT/AST levels, nonalcoholic fatty liver, chronic viral hepatitis, and cirrhosis observations to create the single aggregate variable "liver-related variables" but we retained all other variables. A regression on diabetes using these 11 variables revealed that OR was significant only for reports of diabetes in 
Rates of Diabetes, Overweight, and Obesity in Probands and General Population
Comparisons of the present probands with those of a 2010 general population sample from the Birmingham-Hoover metropolitan area of Alabama demonstrate that the prevalence rates of diabetes diagnosis, overweight, or obese in the probands did not differ significantly from those of the general population sample (Table 3) .
Diabetes and Overweight/Obesity Prevalence by Year of Diagnosis
Sixty-eight probands were diagnosed to have hemochromatosis during the interval 1976-1995. Twelve (17.6%) had diabetes. Ninety-one probands were diagnosed to have hemochromatosis during the interval 1996-2010. Eleven (12.1%) had diabetes. Proportions of probands in the two subgroups did not differ significantly (P = 0.32).
In probands diagnosed to have hemochromatosis during the interval 1976-1995, 31 (45.6%) were overweight. In probands diagnosed during the interval 1996-2010, 33 (36.3%) were overweight (P = 0.2356). In probands diagnosed to have hemochromatosis during the interval 1976-1995, 12 (17.6%) were obese. In probands diagnosed during the interval 1996-2010, 35 (38.5%) were obese (P = 0.0044).
CONCLUSIONS
The present results demonstrate that each of the 23 probands with diabetes had type 2 diabetes and that there is a significant positive association of type 2 diabetes at diagnosis of hemochromatosis in nonscreening probands with HFE C282Y homozygosity with their reports of diabetes in firstdegree family members, after correction for other variables. There was no significant statistical contribution of severity of iron overload, cirrhosis, or other liverrelated variables to the occurrence of diabetes in this cohort whose diagnoses of hemochromatosis were ascertained in a uniform manner. In the 19th century through the latter 20th century, the predominant etiology of diabetes in whites with hemochromatosis was generally acknowledged to be severe pancreatic and hepatic iron overload. In the present hemochromatosis cohort, we demonstrate that the predominant etiology of type 2 diabetes may be the inheritance of nonhemochromatosis traits shared with first-degree relatives. These results confirm and extend the postulates of Balcerzak et al. (9) and Dymock et al. (10) that a heritable factor (s) increases risk of diabetes in people with and without hemochromatosis. In subjects unselected for hemochromatosis diagnoses, the risk of type 2 diabetes is also increased in those who have positive family histories of diabetes (24) (25) (26) (27) ).
In the current study, we relied on reports of diabetes in first-degree family members elicited from nonscreening probands at diagnosis of hemochromatosis. In studies of subjects selected without regard to hemochromatosis or iron overload diagnoses, the validity of patient selfreports of diabetes among relatives revealed sensitivities of .60% and specificities as high as 90% (28) (29) (30) (31) . In the Hemochromatosis and Iron Overload Screening (HEIRS) Study, the analytical validity of self-reported family history of hemochromatosis, iron overload, and related disorders was evaluated in 145 index participants with hemochromatosis or iron overload, 549 family members, and 641 control participants. The sensitivity and specificity for diabetes were 58 and 96%, respectively (32) . Accordingly, the true prevalence of diabetes in first-degree family members in the current study may have been higher than that suggested by family history reports.
The OR for diabetes in the present probands was increased in association with reports of maternal diabetes. Maternally transmitted type 2 diabetes in Han Chinese and Finnish subjects has been linked to nonsynonymous mitochondrial DNA variants and rare mitochondrial haplotypes (33, 34) . Taken together, these observations suggest that mitochondrial DNA variants are one mechanism by which type 2 diabetes could be maternally transmitted to people with HFE hemochromatosis. The elevated OR for diabetes in the present probands with sibling reports of diabetes is consistent with the results of family history of diabetes studies in people unselected for hemochromatosis diagnoses (24) (25) (26) (27) . Evaluating observations on diabetes management and complications in probands was beyond the scope of the current study. Likewise, it was not possible to review medical records, BMI, iron measures, and other observations of the first-degree relatives of probands. Thus, we cannot exclude the possibility that BMI in first-degree family members of probands, rather than the proband family histories of diabetes and BMI alone, was a significant independent determinant of diabetes in probands.
We conclude that increased risk for diabetes at hemochromatosis diagnosis in nonscreening HFE C282Y homozygotes is associated with reports of diabetes in first-degree family members and BMI but not with cirrhosis or other liver disorders, other comorbid conditions, iron removed by phlebotomy, or common HLA haplotypes linked to HFE C282Y on chromosome 6p.
